Behind The Labs

Behind The Labs
  • 0,0 (0)
  • Life Science
  • Varje vecka

A podcast where we explore new studies in the world, relating to biological advancements and more, and we also speak to experts on these topics. Get ready to learn more about what goes on Behind The Labs!

  1. 24 juni

    Behind The Labs - Episode 56 - Preventing and Reversing Neurodegenerative Diseases and the Physiological-Psychological Connection that Can Help Identify Personalized Medicine and Medication!

    In this episode of Behind The Labs, we broke down five major research studies pushing the boundaries of neuroscience and medicine. We covered Northwestern's experimental drug NU-9, which may prevent Alzheimer's before symptoms ever appear by targeting a newly identified toxic amyloid subtype. We then talked about Japanese researchers engineering a supercharged vitamin K compound that can actually regenerate lost neurons — a first for the field. Johns Hopkins blew our minds with pea-sized lab-grown brains that can distinguish schizophrenia from bipolar disorder with 92% accuracy, opening the door to personalized psychiatric treatment. On the prevention side, a massive meta-analysis confirmed that eating legumes and soy foods daily can cut hypertension risk by nearly 30%, and NYU researchers found a simple blood test that detects depression through accelerated immune cell aging — before you even feel it. The big theme across all of it: medicine is shifting from treating disease after the damage is done to catching and stopping it years earlier.

    38 min

  2. 22 maj

    Behind The Labs - Episode 55 - The Brain's Role in Endurance & Stamina, The Cognitive Benefits of Creatine, and Saying Um or Uh Could Point to Future Dementia?

    Today at Behind The Labs, we’re looking at five recent health-related studies that sound very different on the surface: exercise, dementia, Alzheimer’s disease, semaglutide, and creatine. But there’s a common theme across all of them: health is not just about one organ, one habit, or one simple cause. The brain affects endurance. Speech may reveal cognitive decline. Blood vessels may shape Alzheimer’s disease. Weight-loss medication may help older adults but still requires caution. Creatine may support more than muscle.

    33 min

  3. 4 maj

    Behind The Labs - Episode 54 - Early Morning Alternative to Caffeine, Challenging Your Brain = Reduced Risk of Alzheimer's, and Pain is a Maintained Neural Process?

    In this episode of Behind the Labs, we explore cutting-edge research that’s reshaping how we understand sleep, brain health, and chronic pain. We start with a clinical trial on solriamfetol, a wake-promoting drug showing promising results for early morning shift workers—a group often overlooked despite facing major circadian rhythm disruptions. The findings highlight how aligning (or misaligning) with our biological clock can dramatically impact alertness, performance, and overall well-being. We also dive into a Lancet-published study on sulthiame, a potential game-changer for obstructive sleep apnea, offering hope for patients who struggle with traditional CPAP therapy by directly improving breathing regulation during sleep. Beyond sleep, we unpack research on lifelong cognitive engagement and its link to reduced Alzheimer’s risk, emphasizing the idea of “cognitive reserve” and how habits like reading and learning may delay neurodegeneration by years. Finally, we discuss groundbreaking neuroscience uncovering a brain circuit in the insular cortex that may actively sustain chronic pain—challenging the notion that pain simply lingers after injury. Together, these studies reveal how deeply interconnected our brain, behavior, and biology are, while pointing toward innovative treatments that could transform patient care in the future.

    30 min

  4. 22 apr.

    Behind The Labs - Episode 53 - The Gene Mutation Behind Deafness, Astrocytes As Memory Regulators, and Completely Revolutionizing the Intracellular Protein Pathway!

    In this episode of Behind the Labs, we explored a series of studies that challenge some of the most fundamental assumptions in biology and medicine. From the brain to the lungs to individual cells, researchers are uncovering active, dynamic systems where we once thought processes were passive. We discussed how astrocytes—long considered mere support cells—actually play a direct role in encoding and controlling fear memories, reshaping how we understand emotional regulation and disorders like PTSD. We also looked at a breakthrough in gene therapy that successfully restored hearing in patients with genetic deafness, highlighting the growing potential of precision medicine to not just manage, but potentially cure sensory disorders. We then turned to aging and disease, examining how changes in lung tissue—not just immune decline—can drive severe outcomes in infections like COVID-19 through runaway inflammation. Finally, we covered a discovery showing that cells actively transport proteins using internal “trade winds,” challenging the classic diffusion model and offering new insight into processes like wound healing and cancer metastasis. Together, these studies paint a picture of biology as far more active, interconnected, and targetable than previously thought—opening the door to entirely new therapeutic strategies.

    30 min

  5. 17 mars

    Behind The Labs - Episode 52 - Vitamin C Vs. COVID-19, Microplastics Leading to Neurodegenerative Diseases, and Paternal Nicotine Exposure Effects Child Metabolic Health

    In this episode of Behind the Labs, we explore several new studies that reveal how everyday exposures and biological processes can influence human health. We begin with the VIVID clinical trial, which tested whether high-dose vitamin D supplements could reduce the severity of COVID-19 or prevent infection within households. While the study found no meaningful effect on acute illness or transmission, researchers observed a possible small reduction in long-COVID symptoms among participants who closely followed the supplementation regimen. We also discuss research on paternal nicotine exposure, where scientists discovered that nicotine use in fathers before conception altered metabolic pathways in their offspring, suggesting that a father’s health habits may influence the long-term disease risk of future children. The episode then shifts to environmental and neurological health, highlighting a systematic review suggesting that microplastics could contribute to neurodegenerative diseases such as Alzheimer’s and Parkinson’s through mechanisms like inflammation, oxidative stress, and mitochondrial dysfunction. We also cover a study showing that THC intoxication can significantly impair multiple types of memory, including prospective memory and source memory, even at moderate doses. Finally, we examine new research linking cellular energy metabolism to depression, where abnormal ATP production patterns may help explain fatigue and cognitive symptoms in patients, as well as a clinical trial showing that the drug sulthiame may reduce breathing interruptions in obstructive sleep apnea, offering a potential alternative treatment to CPAP machines. Together, these studies highlight how advances in biomedical research continue to uncover unexpected connections between environment, behavior, and disease.

    28 min

  6. 28 feb.

    Behind The Labs - Episode 51 - Cancer Eating Bacteria, Diet-Induced Thermogenesis, and Stem Cell Derived Parkinson's Treatment?

    This week on Behind the Labs, we break down four cutting-edge studies reshaping how we think about metabolism, aging, cancer therapy, and early development. First, researchers show that reducing specific amino acids in the diet can boost thermogenesis and fat burning in mice—without more exercise. Next, a UCLA team reveals why aging muscle stem cells slow down: a survival protein keeps them alive longer but at the cost of repair speed. We also explore an innovative cancer strategy using engineered bacteria to infiltrate and consume oxygen-starved tumor cores, and a promising stem cell trial aiming to restore dopamine-producing neurons in Parkinson’s disease. Finally, new genome-mapping technology overturns the “blank slate” model of early embryos, showing DNA is highly organized far earlier than scientists thought. Together, these studies highlight a common theme in modern biology: powerful trade-offs underlie many of the body’s most important systems.

    30 min

  7. 16 feb.

    Behind The Labs - Episode 50 - Periodontal Disease, ADHD Medication vs CBT, and AI in the ER!

    This week on Behind the Labs, we’re diving into five studies that challenge what we think we know about the brain, the body, and even what makes us human. Let’s start with something almost philosophical. Researchers showed that a bonobo named Kanzi can track imaginary objects in controlled experiments — like pretend juice being poured into a cup. He consistently identified where the “imaginary” object was, even after the cups were moved. That’s a big deal because imagination — the ability to mentally represent something that isn’t physically there — has long been considered uniquely human. If apes share even part of that ability, it suggests imagination may have evolutionary roots going back millions of years. Next, shifting to human health — a large U.S. study found that people with the highest intake of ultra-processed foods had a 47% higher risk of cardiovascular disease. These foods now make up about 60% of adult diets in the U.S. The concern isn’t just calories — it’s how heavily altered these foods are and how they may drive inflammation and metabolic dysfunction. It raises the question: are we engineering convenience at the cost of long-term cardiovascular health? On a more specific nutrition note, another study found that older adults who don’t consume enough lycopene — the antioxidant found in tomatoes — have significantly higher odds of severe gum disease. What’s interesting is that the protective effect varied by race and sex, pointing to deeper health disparities that diet alone may not fully explain. In mental health research, the most comprehensive review ever conducted on ADHD treatments confirmed that medication remains the most evidence-supported intervention for both children and adults, with cognitive behavioral therapy strongly supported for adults. Many alternative approaches showed weaker evidence. The researchers even launched an interactive platform to help patients and clinicians navigate treatment options more transparently — which speaks to how overwhelming and contradictory mental health advice can feel. Then there’s AI in medicine. A new system called Prima can analyze brain MRIs in seconds with up to 97.5% accuracy, automatically flagging urgent conditions like stroke. It integrates imaging with patient history — almost like a radiologist co-pilot. In a health system strained by backlogs and specialist shortages, that kind of speed could genuinely change outcomes. And finally — jet lag might someday be solved at the genetic level. Scientists discovered a compound called Mic-628 that directly activates a core circadian gene, effectively pushing the body’s internal clock forward. In animal models, it cut jet lag recovery nearly in half. Unlike melatonin, it doesn’t depend on precise timing. It works through the molecular mechanics of the clock itself. Across all these studies, there’s a common thread: we’re moving from observing biology to directly understanding and influencing its underlying mechanisms — whether that’s imagination in apes, inflammation from food, neural attention systems, real-time medical imaging, or the genes that keep time inside our cells. And that’s what we love about science — it keeps pushing the boundary of what we thought was uniquely human, uniquely biological, or simply impossible.

    54 min

  8. 23 jan.

    Behind The Labs - Episode 49 - Preventing Crohn's Disease in Advance, Ibuprofen as a Preventative Measure to Cancer, and Exercise's Best Effects!

    In this episode, we dive into a series of powerful new studies showing how early detection, lifestyle choices, and cutting-edge therapies are reshaping the future of medicine. We begin with groundbreaking research from Sinai Health revealing a blood test that may predict the risk of Crohn’s disease years before symptoms appear—opening the door to prevention rather than damage control. From there, we explore work from the AdventHealth Research Institute showing that consistent aerobic exercise can make the brain appear biologically younger, highlighting how everyday habits in midlife may protect long-term cognitive health. We then turn to transformative findings from Stanford Medicine, where scientists successfully regenerated joint cartilage in aging and injured mice by blocking an aging-related enzyme—raising real hope for disease-modifying treatments for osteoarthritis that could reduce the need for joint replacement. The episode also covers long-term results from the RECOVER trial led by Washington University School of Medicine, where vagus nerve stimulation produced sustained, life-changing improvements for people with the most severe forms of treatment-resistant depression. Finally, we unpack emerging (and controversial) evidence suggesting that ibuprofen’s anti-inflammatory effects may influence cancer risk—while emphasizing why self-medication is not the answer. Together, these studies paint a compelling picture: medicine is moving earlier, deeper, and more personalized—shifting from managing symptoms to predicting risk, restoring function, and improving quality of life over the long term.

    28 min
Visa alla (57)

Om

A podcast where we explore new studies in the world, relating to biological advancements and more, and we also speak to experts on these topics. Get ready to learn more about what goes on Behind The Labs!

Information

  • Skapad av
    Behind The Labs
  • Aktiva år
    2024 - 2026
  • Avsnitt
    57
  • Åldersgräns
    Barnvänligt
  • Copyright
    © Behind The Labs
  • Programmets webbplats
    Behind The Labs